Behavioral activation vs antidepressants: Which wins for heart failure patients with depression?

The efficacy of antidepressant medication management (MEDS) against behavioral activation psychotherapy (BA).

IIPR Stock Analysis and why IIPR stock will continue to move higher

September 9, 2023

Biotech IPO raising in Q1 2024 surged from Q4 2023 – but has the momentum lasted? – Pharmaceutical Technology

Biotech initial public offerings (IPOs) surged in Q1 2024, with eight completed IPOs raising a total of $3.72bn, six times more than the $621m raised

July 30, 2024

Study reveals heart failure insights at single-cell level

Researchers examined the cell-intrinsic effects of hematopoietic stem cells with somatic mutations in circulating cells from heart failure patients.

September 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.